Australia flags ‘fake’ rabies jab; Indian manufacturer counters claim
Tribune India••health
Key Points:
- Australian health authorities raised concerns about counterfeit versions of the rabies vaccine Abhayrab in India, advising travellers vaccinated after November 1, 2023, to consider their vaccination invalid and restart the course.
- Indian Immunologicals (IIL), the manufacturer of Abhayrab, clarified that the issue involved only a single batch identified in January 2025 and criticized the Australian advisory for referencing 2023 inaccurately.
- IIL highlighted that the affected batch was promptly reported to Indian regulators and law enforcement, with the counterfeit batch now removed from circulation.
- The company stressed its long-standing reputation, having supplied over 210 million doses since 2000, and maintained that all vaccine batches undergo rigorous testing by the Central Drugs
:max_bytes(150000):strip_icc()/Health-GettyImages-2213062284-4dfc94bf563a4927ba8c23452020fee6.jpg)